Sarepta Therapeutics, Inc. (BVMF:S1RP34)
Brazil · Delayed Price · Currency is BRL 4.700
-0.040 (-0.84%)
At close: Nov 12, 2025
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 9.99 billion as of November 13, 2025. Its market cap has decreased by -85.92% in one year.
Market Cap
9.99B
Enterprise Value
12.16B
Revenue
12.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 75.14M to 9.99B, an increase of 13,193.02%. That is a compound annual growth rate of 18.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 9.99B | -86.09% |
| Dec 31, 2024 | 71.83B | 64.11% |
| Dec 29, 2023 | 43.77B | -27.21% |
| Dec 30, 2022 | 60.13B | 37.64% |
| Dec 31, 2021 | 43.69B | -37.47% |
| Dec 31, 2020 | 69.87B | 80.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 37.89B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.60B |
| Empreendimentos Pague Menos | 2.91B |
| Diagnósticos da América | 2.52B |
| Blau Farmacêutica | 2.21B |